Related Experiment Video
Updated: Jan 5, 2026

07:30
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
8.7K
Molecular Targets for Improving Arteriovenous Fistula Maturation and Patency
Jolanta Gorecka1, Arash Fereydooni1, Luis Gonzalez1
1Vascular Biology and Therapeutics Program and the Department of Surgery, Yale School of Medicine, Yale University, New Haven, USA.
Summary
Arteriovenous fistulae (AVF) are crucial for hemodialysis but often fail. Understanding molecular changes, particularly Eph receptor signaling, may improve AVF maturation and patency rates.
Area of Science:
- Vascular biology
- Renal medicine
- Molecular signaling
Background:
- Chronic kidney disease necessitates reliable hemodialysis access.
- Arteriovenous fistulae (AVF) are preferred but face significant maturation and patency issues.
- AVF failure stems from inadequate outward remodeling or excessive neointimal hyperplasia.
Purpose of the Study:
- To review molecular mechanisms underlying AVF maturation and failure.
- To identify factors predicting AVF success.
- To explore therapeutic targets for improving AVF outcomes.
Main Methods:
- Review of current literature on AVF molecular biology.
- Analysis of extracellular matrix remodeling, inflammation, and growth factor signaling in AVF.
- Examination of the role of Eph receptors and ephrins in vascular remodeling.
Main Results:
- AVF maturation involves complex extracellular matrix remodeling, inflammation, and cell signaling.
- Early AVF failure is linked to insufficient outward remodeling.
- Late AVF failure is associated with neointimal hyperplasia and reduced patency.
Conclusions:
- Eph receptor signaling is critical for vascular remodeling and presents a potential therapeutic target.
- Targeting molecular pathways can enhance AVF maturation and prevent access loss.
- Further research into molecular interventions is needed to improve hemodialysis access.
Related Concept Videos
Hemodialysis I: Introduction
1.1K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K

